Multidrug resistance and cancer stem cells in neuroblastoma and hepatoblastoma

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Chemotherapy is one of the major modalities in treating cancers. However, its effectiveness is limited by the acquisition of multidrug resistance (MDR). Several mechanisms could explain the up-regulation of MDR genes/proteins in cancer after chemotherapy. It is known that cancer stem cells (CSCs) play a role as master regulators. Therefore, understanding the mechanisms that regulate some traits of CSCs may help design efficient strategies to overcome chemoresistance. Different CSC phenotypes have been identified, including those found in some pediatric malignancies. As solid tumors in children significantly differ from those observed in adults, this review aims at providing an overview of the mechanistic relationship between MDR and CSCs in common solid tumors, and, in particular, focuses on clinical as well as experimental evidence of the relations between CSCs and MDR in neuroblastoma and hepatoblastoma. Finally, some novel approaches, such as concomitant targeting of multiple key transcription factors governing the stemness of CSCs, as well as nanoparticle-based approaches will also be briefly addressed.

Original languageEnglish
Pages (from-to)24706-24725
Number of pages20
JournalInternational Journal of Molecular Sciences
Volume14
Issue number12
DOIs
Publication statusPublished - Dec 18 2013

Fingerprint

Hepatoblastoma
Neoplastic Stem Cells
stem cells
Multiple Drug Resistance
Stem cells
Neuroblastoma
cancer
Chemotherapy
Neoplasms
Tumors
chemotherapy
P-Glycoproteins
MDR Genes
Drug Therapy
Pediatrics
Transcription factors
tumors
Nanoparticles
phenotype
regulators

Keywords

  • Cancer stem cells
  • Hepatoblastoma
  • Multidrug resistance
  • Neuroblastoma

ASJC Scopus subject areas

  • Computer Science Applications
  • Molecular Biology
  • Catalysis
  • Inorganic Chemistry
  • Spectroscopy
  • Organic Chemistry
  • Physical and Theoretical Chemistry

Cite this

Multidrug resistance and cancer stem cells in neuroblastoma and hepatoblastoma. / Alisi, Anna; Cho, William C.; Locatelli, Franco; Fruci, Doriana.

In: International Journal of Molecular Sciences, Vol. 14, No. 12, 18.12.2013, p. 24706-24725.

Research output: Contribution to journalArticle

@article{46ba471829cd45928ad49ef6677ade1d,
title = "Multidrug resistance and cancer stem cells in neuroblastoma and hepatoblastoma",
abstract = "Chemotherapy is one of the major modalities in treating cancers. However, its effectiveness is limited by the acquisition of multidrug resistance (MDR). Several mechanisms could explain the up-regulation of MDR genes/proteins in cancer after chemotherapy. It is known that cancer stem cells (CSCs) play a role as master regulators. Therefore, understanding the mechanisms that regulate some traits of CSCs may help design efficient strategies to overcome chemoresistance. Different CSC phenotypes have been identified, including those found in some pediatric malignancies. As solid tumors in children significantly differ from those observed in adults, this review aims at providing an overview of the mechanistic relationship between MDR and CSCs in common solid tumors, and, in particular, focuses on clinical as well as experimental evidence of the relations between CSCs and MDR in neuroblastoma and hepatoblastoma. Finally, some novel approaches, such as concomitant targeting of multiple key transcription factors governing the stemness of CSCs, as well as nanoparticle-based approaches will also be briefly addressed.",
keywords = "Cancer stem cells, Hepatoblastoma, Multidrug resistance, Neuroblastoma",
author = "Anna Alisi and Cho, {William C.} and Franco Locatelli and Doriana Fruci",
year = "2013",
month = "12",
day = "18",
doi = "10.3390/ijms141224706",
language = "English",
volume = "14",
pages = "24706--24725",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "MDPI AG",
number = "12",

}

TY - JOUR

T1 - Multidrug resistance and cancer stem cells in neuroblastoma and hepatoblastoma

AU - Alisi, Anna

AU - Cho, William C.

AU - Locatelli, Franco

AU - Fruci, Doriana

PY - 2013/12/18

Y1 - 2013/12/18

N2 - Chemotherapy is one of the major modalities in treating cancers. However, its effectiveness is limited by the acquisition of multidrug resistance (MDR). Several mechanisms could explain the up-regulation of MDR genes/proteins in cancer after chemotherapy. It is known that cancer stem cells (CSCs) play a role as master regulators. Therefore, understanding the mechanisms that regulate some traits of CSCs may help design efficient strategies to overcome chemoresistance. Different CSC phenotypes have been identified, including those found in some pediatric malignancies. As solid tumors in children significantly differ from those observed in adults, this review aims at providing an overview of the mechanistic relationship between MDR and CSCs in common solid tumors, and, in particular, focuses on clinical as well as experimental evidence of the relations between CSCs and MDR in neuroblastoma and hepatoblastoma. Finally, some novel approaches, such as concomitant targeting of multiple key transcription factors governing the stemness of CSCs, as well as nanoparticle-based approaches will also be briefly addressed.

AB - Chemotherapy is one of the major modalities in treating cancers. However, its effectiveness is limited by the acquisition of multidrug resistance (MDR). Several mechanisms could explain the up-regulation of MDR genes/proteins in cancer after chemotherapy. It is known that cancer stem cells (CSCs) play a role as master regulators. Therefore, understanding the mechanisms that regulate some traits of CSCs may help design efficient strategies to overcome chemoresistance. Different CSC phenotypes have been identified, including those found in some pediatric malignancies. As solid tumors in children significantly differ from those observed in adults, this review aims at providing an overview of the mechanistic relationship between MDR and CSCs in common solid tumors, and, in particular, focuses on clinical as well as experimental evidence of the relations between CSCs and MDR in neuroblastoma and hepatoblastoma. Finally, some novel approaches, such as concomitant targeting of multiple key transcription factors governing the stemness of CSCs, as well as nanoparticle-based approaches will also be briefly addressed.

KW - Cancer stem cells

KW - Hepatoblastoma

KW - Multidrug resistance

KW - Neuroblastoma

UR - http://www.scopus.com/inward/record.url?scp=84890953102&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890953102&partnerID=8YFLogxK

U2 - 10.3390/ijms141224706

DO - 10.3390/ijms141224706

M3 - Article

C2 - 24351843

AN - SCOPUS:84890953102

VL - 14

SP - 24706

EP - 24725

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 12

ER -